Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemodectoma of the larynx.

J A Crowther1, B H Colman

  • 1Department of Otolaryngology, Stobhill Hospital, Glasgow.

The Journal of Laryngology and Otology
|October 1, 1987
PubMed
Summary

This study presents two laryngeal chemodectoma cases, highlighting distinctions between benign and malignant tumors. Early differentiation and treatment strategies for these rare laryngeal neoplasms are discussed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How many growing vestibular schwannomas tend to stop growing without any treatment?

The Journal of laryngology and otology·2022
Same author

Benefits of pre-labyrinthectomy intratympanic gentamicin: contralateral vestibular responses.

The Journal of laryngology and otology·2019
Same author

Cochlear patency following translabyrinthine vestibular schwannoma resection: implications for hearing rehabilitation.

The Journal of laryngology and otology·2019
Same author

Findings on 7000 MRI of the IAM: To scan or not to scan?: A retrospective cohort study.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2018
Same author

Quality of life in patients with vestibular schwannomas managed conservatively.

Clinical otolaryngology and allied sciences·2004
Same author

Growth rate of non-vestibular intracranial schwannomas.

Clinical otolaryngology and allied sciences·2004

Area of Science:

  • Otolaryngology
  • Pathology
  • Oncology

Background:

  • Laryngeal chemodectomas are rare neuroendocrine tumors arising from paraganglia in the larynx.
  • Distinguishing between benign and malignant variants is crucial for appropriate patient management.
  • Limited data exists on early diagnostic markers and optimal treatment protocols.

Purpose of the Study:

  • To present two distinct cases of laryngeal chemodectoma.
  • To elucidate the clinicopathological differences between benign and malignant laryngeal chemodectomas.
  • To propose a diagnostic and therapeutic strategy for laryngeal chemodectomas.

Main Methods:

  • Case report presentation of two patients with laryngeal chemodectoma.
  • Review of histopathological findings and clinical presentation.
  • Discussion of diagnostic challenges and treatment options.

Main Results:

  • The cases illustrate key differences in presentation and behavior between benign and malignant laryngeal chemodectoma.
  • Early differentiation remains a challenge, necessitating a high index of suspicion.
  • A potential treatment policy is outlined based on tumor characteristics.

Conclusions:

  • Accurate early diagnosis of laryngeal chemodectoma subtypes is essential for effective management.
  • A multidisciplinary approach may be required for optimal treatment of laryngeal chemodectoma.
  • Further research is warranted to refine diagnostic criteria and treatment guidelines for laryngeal chemodectoma.

Related Experiment Videos